Some mutants in the calcium-sensing receptor (CaSR) leading to familial hypocalciuric hypercalcemia and neonatal hyperparathyroidism can also be rescued using membrane-permeant allosteric agonists to recover protein functionality [190,295]. The gene discussed is CASR; the disease is familial hypocalciuric hypercalcemia.